Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asymmetrex
Boston (or Cambridge) *see note below*, Massachusetts, United Statesasymmetrex.co ↗
- Ownership
- Private
- Employees
- ~1
- Development stage
- Preclinical
01
Overview
Asymmetrex has pioneered patented kinetic stem cell counting technologies that enable accurate differential quantification of adult tissue stem cells from heterogeneous samples. Their innovations address a longstanding barrier in regenerative medicine by providing reliable methods to determine the dose and quality of therapeutic stem cells used in research, manufacturing, transplantation therapies, gene/cell therapies, and drug development. The company offers free online calculators as well as contract services using their proprietary algorithms. They are developing an automated benchtop device with NIH funding to further streamline this process.
- Therapeutic areas
- GastroenterologyOther
- Modalities
- Cell therapy (adult tissue stem cells)Enabling technology for cell-based therapies and drug development
- Industry
- Non-Drug Biotech
02
Partnerships
AlphaSTAR Corp.—jointly developing AlphaSTEM technology for identifying pharmaceutical drug candidates toxic to tissue stem cells.Looma Design—engineering partner on automated counter device project.Collaborative projects with Adeptrix Corporation & University of New Hampshire via ARMI/BioFabUSA grant proposal.
Beyond the preview
Go deeper on Asymmetrex.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Asymmetrex.